Journal article

Diagnostic measures for evaluation of thrombophilia


Authors listKemkes-Matthes, B

Publication year2001

Pages433-437

JournalZentralblatt für Chirurgie

Volume number126

Issue number6

ISSN0044-409X

DOI Linkhttps://doi.org/10.1055/s-2001-14762

PublisherGeorg Thieme Verlag


Abstract
Using laboratory testing, coagulation alterations can be detected in about 50 % of familial thrombophilia. Most common hereditary coagulation defects leading to enhanced thrombosis risk are aPC resistance/Factor V Leiden mutation, protein C- and S-deficiency, prothrombin 20210A polymorphism and antithrombin deficiency. Moreover, elevated plasma levels of homocysteine also are associated with enhanced thrombosis risk. Severity of thromboembolic risk depends upon type of coagulation defect, hetero- or homocygosity and occurrence of additional acquired risk factors like immobilisation. Therapy of thromboembolic diseases must always be planned considering both clinical circumstances and laboratory findings.



Citation Styles

Harvard Citation styleKemkes-Matthes, B. (2001) Diagnostic measures for evaluation of thrombophilia, Zentralblatt für Chirurgie, 126(6), pp. 433-437. https://doi.org/10.1055/s-2001-14762

APA Citation styleKemkes-Matthes, B. (2001). Diagnostic measures for evaluation of thrombophilia. Zentralblatt für Chirurgie. 126(6), 433-437. https://doi.org/10.1055/s-2001-14762



Keywords


Factor V Leidenprotein Cprotein Sprothrombin polymorphismthromboembolic riskVENOUS THROMBOSIS

Last updated on 2025-02-04 at 07:29